Abstract
Several thousand nitroheterocyclic compounds, particularly derivatives of furan, thiazole, and imidazole, have been synthesized and subjected to some degree of biological evaluation. (See reviews by Paul and Paul 1964, 1966; Miura and Reckendorf, 1967; Grunberg and Titsworth, 1973; and McCalla, 1979.) Several of these compounds are or have been widely used as antibacterial and antiprotozoal agents, and development of new nitroheterocyclic compounds continues at a rapid pace. However, in the past decade it has become clear that some of these compounds are carcinogenic (Bryan, 1978), and an extensive literature now shows that essentially all nitroheterocycles are mutagenic to Escherichia coli and to the strains of Salmonella typhimurium that contain the pKM 101 plasmid (Tazima et al. 1975; McCann et al. 1975a,b; Klemenic and Wang, 1978).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adams, G.E., Clarke, E.D., Jacobs, R.S., Stratford, I.J., Wallace, R.G., Wardman, P., Watts, M.E. (1976): Mammalian cell toxicity of nitro compounds; dependence upon reduction potential. Biochem. Biophys. Res. Comm. 72: 824–829.
Ames, B.N., McCann, J., Yamasaki E. (1975): Methods for detecting carcinogens and mutagens with the Salmonella/mammalian microsome mutagenicity test. Mutat. Res. 31: 347–364.
Asnis, R.E. (1957): The reduction of furacin by cell-free extracts of furacin-resistant and parent-susceptible strains of Escherichia coli. Arch. Biochem. Biophys. 66: 208–216.
Boyd, M.R., Stiko, A.W., Sasame, H.A. (1979): Metabolic activation of nitrofurantoin—possible implications for carcinogenesis. Biochem. Pharmacol. 28: 601–606.
Bryan, G.T. (ed.) (1978): Nitrofurans: Carcinogenesis—A Comprehensive Survey, Vol. 4. New York: Raven Press.
Butler, W.H., Barnes, J.M. (1966): Carcinoma of the glandular stomach in rats given aflatoxin. Nature (Lond.) 209: 90.
Chessin, H., McLaughlin T., Mroczkowski, Z., Rupp, W.D., Low K.B. (1978): Radiosensitization, mutagenicity and toxicity of Escherichia coli by several nitrofurans and nitroimidazoles. Radiat. Res. 75: 424–431.
Ebetino, F.F., Carroll, J.J., Gever, G. (1962): Reduction of nitrofurans I: aminofurans. J. Med. Pharm. Chem. 5: 513–524.
Feller, D.R., Morita, M., Gillette, J.R. (1971): Reduction of heterocyclic nitro compounds in the rat liver. Proc. Soc. Exp. Biol. Med. 137: 433–437.
Flamm, G. (1979): Discussion. In: V.K. McElheny, E. Abrahamson (eds.), Banbury Rept. 1: Assessing Chemical Mutagens: The Risk to Humans. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, p. 95.
Gavin, J.J., Ebetino, F.F., Freedman, R., Waterbury, W.E. (1966): The aerobic degradation of 1 -(5-nitrofurfuryl ideneamino)-2-imidazalone (NF-246) by Escherichia coli. Arch. Biochem. Biophys. 1 73: 399–404.
Green, M.H.L., Muriel, W.J. (1976): Mutagen testing using the TRP+ reversion in E. coli. Mutat. Res. 38: 3–32.
Green, M.H.L., Rogers, A.M., Ward, A.C., McCalla, D.R. (1977): Use of a simplified fluctuation test to detect and characterize mutagenesis by nitrofurans. Mutat. Res. 44: 139–143.
Grunberg, E., Titsworth, E.H. (1973): Chemotherapeutic properties of heterocyclic compounds: Monocyclic compounds with fivemembered rings. Ann. Rev. Microbiol. 27: 317–346.
Jacobs, J.B., Arai, M., Cohen, S.M., Friedell, G.H. (1977): A long-term study of reversible and progressive urinary bladder cancer lesions in rats fed N-[4-(5-nitro-2-furyl)-2thiazolyl]formamide. Cancer Res. 37: 2817–2821.
Jovin, T.M., Dante, M.L., Cramback, A. (1970): Multiphasic Buffer Systems Output, Document No. PB259311. Springfield, Virginia, National Technical Information Service.
Kada, T. (1973): Escherichia coli mutagenicity of furylfuramide. Jap. J. Genetics 48: 301–305.
Kada, T. (1974): Metabolic activation and Escherichia coli mutagenesis of furylfuramide, a nitrofuran food additive. Ann. Rep. Natl. Inst. Genet. Jap. 24: 39–41.
King, H.W.S., Thompson, M.H., Brookes, P. (1975): The benzo(a)pyrene deoxyribonucleoside products isolated from DNA after metabolism of benzo(a)pyrene by rat liver microsomes in the presence of DNA. Cancer Res. 35: 1263–1269.
Klemenic, J.M., Wang, C.Y. (1978): Mutagenicity of nitrofurans. In: G.T. Bryan (ed.), Nitrofurans: Carcinogenesis—A Comprehensive Survey, Vol. 4. New York: Raven Press, pp. 99–130.
Lu, C., McCalla, D.R., Bryant, D.W. (1979): Action of nitrofurans on E. coli: Mutation and induction and repair of daughter-strand gaps in DNA. Mutat. Res. 67: 133–144.
Mason, R.P., Holtzman, J.L. (1975a): The role of catalytic superoxide formation in the 02 inhibition of nitroreductase. Biochem. Biophys. Res. Commun. 67: 1267–1274.
Mason, R.P., Holtzman, J.L. (1975b): The mechanism of microsomal and mitochondrial nitroreductase. Electron spin resonance evidence for nitroaromatic free radical intermediates. Biochemistry 14: 1626–1632.
McCalla, D.R. (1979): Nitrofurans. In: F.E. Hahn (ed.), Antibiotics, Vol. 1, Mechanism of Action of Antibacterial Agents. Berlin: Springer-Verlag.
McCalla D.R., Voutsinos D. (1974): On the mutagenicity of nitrofurans. Mutat. Res. 36: 3–15.
McCalla, D.R., Voutsinos, D. (1975): Nitrofuran-reducing enzymes of Euglena. J. Protozool. 22: 130–134.
McCalla, D.R., Reuvers, A., Kaiser, C. (1970): Mode of action of nitrofurazone. J. Bacteriol. 70: 1126–1134.
McCalla, D.R., Reuvers, A., Kaiser, C. (1971): Activation of nitrofurazone in animal tissues. Biochem. Pharmacol. 20: 3532–3537.
McCalla, D.R., Olive, P., Tu, Y., Fan, M.L. (1975): Nitrofurazone-reducing enzymes in E. coli and their role in drug-activation in vivo. Can. J. Microbiol. 21: 1484–1491.
McCalla, D.R., Arlett, C.F., Broughton, B. (1978a): The action of AF2 on cultured hamster and human cells under aerobic and hypoxic conditions. Chem.-Biol. Interact. 21: 89–102.
McCalla, D.R., Kaiser C., Green, M.H.L. (1978b): The genetics of nitrofurazone resistance in Escherichia coli. J. Bacteriol. 133: 10–16.
McCann, J., Ames, B.N. (1976): Detection of carcinogens and mutagens in the Salmonella I microsome test: Assay of 300 chemicals: Discussion, Proc. Natl. Acad. Sci. USA 73: 950–954.
McCann, J., Choi, E., Yamasaki, E., Ames, B.N. (1975a): Detection of carcinogens as mutagens in the Salmonella/microsome test: Assay of 300 chemicals. Proc. Natl. Acad. Sci. USA 72: 5135–5139.
McCann, J. Springharn, N.E. Kobori, J., Ames, B.N. (1975b): Detection of carcinogens as mutagens: Bacterial tester strains with R factor plasmids. Proc. Natl. Acad. Sci. USA 72: 979–983.
Meselson, M., Russell, K. (1977): Comparisons of carcinogenic and mutagenic potency. In: H.H. Hiatt, J.D. Watson, J.A. Winsten (eds.), Origins of Human Cancer, Book C, Cold Spring Harbor Laboratory, New York, pp. 1473–1481.
Miura, K., Reckendorf, H.K. (1967): The nitrofurans. Prog. Med. Chem. 5: 320–381.
Mohindra, J.K., Rauth, A.M. (1976): Increased cell killing by metronidazole and nitrofurazone of hypoxic compared to aerobic mammalian cells. Cancer Res. 36: 930–936.
Nakamura, N., Suzuki, N., Okada, S. (1977): Mutagenicity of furylfuramide, a food preservative tested by using alanine-requiring mouse L5178 Y cells in vitro and in vivo. Mutat. Res. 46: 355–364.
Olivard, J., Valenti, S., Buzard, J.A. (1962): The metabolism of 5-nitro-2-furaldehyde acetylhydrazone. . 5: 524–531.
Olive, P.L., McCalla, D.R. (1975): Damage to mammalian cell DNA by nitrofurans. Cancer Res. 55: 781–784.
Olive, P.L., McCalla, D.R. (1977): Cytoxicity and DNA damage to mammalian cells by nitrofurans. Chem. Biol. Interact. 76: 223–233.
Paul, H.E., Paul, M.F. (1964): The nitrofurans—chemotherapeutic properties. Experimental Chemotherapy 77: 307–370.
Paul, H.E., Paul, M.F. (1966): The nitrofurans-chemotherapeutic properties. Experimental Chemotherapy 7F: 521–536.
Peterson, F.J., Mason, R.P., Hovsepian, J., Holtzman, J.L. (1979): Oxygen-sensitive and insensitive nitroreduction by Escherichia coli and rat hepatic microsomes. J. Biol. Chem. 254: 4009–4014.
Rosenkranz, H.S. (1977): Studies on the mutagenicity of nitrofurans in Salmonella typhimurium. Biochem. Pharmacol. 26: 896–898.
Rosenkranz, H.S., Speck, W.T. (1975): Mutagenicity of metronidazole: activation by mammalian liver microsomes. Biochem. Biophys. Res. Commun. 66: 520–525.
Rosenkranz, H.S., Speck W.T. (1976): Activation of nitrofurantoin to a mutagen by rat liver nitroreductase. Biochem. Pharmacol. 25: 1555–1556.
Takayama, S., Kuwabara, N. (1977): The production of skeletal muscle atrophy and mammary tumors in rats by feeding 2-(2-furyl)-3(5-nitro-2-furyl)acrylamide. Toxicol. Lett.: 11–16.
Tatsumi, K., Kitamura, S., Yoshimura, H. (1976): Reduction of nitrofuran derivatives by xanthine oxidase and microsomes. Arch. Biochem. Biophys. 775: 131–137.
Taylor, J.D., Paul, H.E., Paul, F.M. (1951): Metabolism of nitrofurans III. Studies with xanthine oxidase in vitro. J. Biol. Chem. 191: 223–231.
Tazima, Y., Kada, T., Murakami, A. (1975): Mutagenicity of nitrofuran derivatives, including furylfuramide, a food preservative. Mutat. Res. 52: 55–80.
Wang, C.Y., Chiu, C.W., Kaiman, B., Bryan, G.T. (1975): Identification of 2-methyl-4-(5amino-2-furyl)thiazole as the reduced metabolite of 2-methyl-4-(5-nitro-2-furyl) thiazole. Biochem. Pharmacol. 24: 291–293.
Wogan, G.N., Newberne, P.M. (1967): Dose response characteristics of aflatoxin Bi carcinogenesis in the rat. Cancer Res. 27: 2370–2376.
Wolpert, M.K., Althaus, J.R., Johns, D.G. (1973): Nitroreductase activity of mammalian liver aldehyde oxidase. J. Pharmacol. Exp. Ther. 755: 202–213.
Yahagi, T., Nagao, M., Hara, K., Matsushima, T. Sugimura, T., Bryan, G.T. (1974): Relationships between the carcinogenic and mutagenic or DNA-modifying effects of nitrofuran derivatives, including 2-(2-furyl)-3(5-nitro-2-furyl)acrylamide, a food additive. Cancer Res. 34: 2266–2273.
Yahagi, T., Matsushima, T., Nagao, M., Seino, Y., Sugimura, T., Bryan, G.T. (1976): Mutagenicities of nitrofuran derivatives on a bacterial tester strain with an R. factor plasmid. Mutat. Res. 40: 9–14.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1981 Springer-Verlag New York Inc.
About this paper
Cite this paper
McCalla, D.R. (1981). Metabolic Activation of Nitroheterocyclic Compounds in Bacteria and Mammalian Cells. In: Stich, H.F., San, R.H.C. (eds) Short-Term Tests for Chemical Carcinogens. Topics in Environmental Physiology and Medicine. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-5847-6_4
Download citation
DOI: https://doi.org/10.1007/978-1-4612-5847-6_4
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4612-5849-0
Online ISBN: 978-1-4612-5847-6
eBook Packages: Springer Book Archive